STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
Constitutively activated STAT3 plays an essential role in the initiation, progression, maintenance, malignancy, and drug resistance of cancer, including glioblastoma, suggesting that STAT3 is a potential therapeutic target for cancer therapy. We recently identified ODZ10117 as a small molecule inhib...
Main Authors: | Byung-Hak Kim, Haeri Lee, Cheol Gyu Park, Ae Jin Jeong, Song-Hee Lee, Kum Hee Noh, Jong Bae Park, Chung-Gi Lee, Sun Ha Paek, Hyunggee Kim, Sang-Kyu Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/722 |
Similar Items
-
Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
by: Byung-Hak Kim, et al.
Published: (2019-11-01) -
Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of ODZ1 Gene Expression
by: Carlos Velásquez, et al.
Published: (2019-10-01) -
Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Glioblastoma
by: Yasaman Iranmanesh, et al.
Published: (2021-02-01) -
Photometric Solutions of W UMa Type Stars: GSC2576-0319 and GSC2584-1731
by: Chung-Uk Lee, et al.
Published: (2006-12-01) -
The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
by: Agathe L. Chédeville, et al.
Published: (2021-02-01)